« Previous
Trends in Cardiovascular Medicine
Volume 16, Issue 2
, Pages 60-64
, February 2006
Atherosclerosis and the Lectin-like OXidized Low-Density Lipoprotein Scavenger Receptor
References
- . Role of lectin-like oxidized low-density lipoprotein receptor–1 (LOX-1) in the development of hypertensive organ damage. Clin Exp Nephrol. 2004;8:178–182
- Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun. 2001;282:153–158
- Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation. 2003;107:3146–3151
- Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000;275:12633–12638
- The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor–1 reduces the intracellular concentration of nitric oxide in endothelial cells. J Am Coll Cardiol. 2003;41:499–507
- Hemodynamics and the focal origin of atherosclerosis: a spatial approach to endothelial structure, gene expression, and function. Ann NY Acad Sci. 2001;947:7–16
- . Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695
- Lectin-like oxidized LDL receptor–1 (LOX-1) supports adhesion of mononuclear leukocytes and a monocyte-like cell line THP-1 cells under static and flow conditions. FEBS Lett. 2002;511:133–138
- Serum soluble lectin-like oxidized low-density lipoprotein receptor levels are elevated in acute coronary syndrome. A novel marker for early diagnosis. Circulation. 2005;112:812–818
- . Oxidized LDL induces enhanced antibody formation and MHC class II–dependent IFN-gamma production in lymphocytes from healthy individuals. Arterioscler Thromb Vasc Biol. 1995;15:1577–1583
- Overexpression of lectin-like oxidized low-density lipoprotein receptor–1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ Res. 2005;97:176–184
- . A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor–1. Proc Natl Acad Sci USA. 2000;97:360–364
- Expression of lectin-like oxidized low-density lipoprotein receptor–1 in human atherosclerotic lesions. Circulation. 1999;99:3110–3117
- Oxidized LDL modulates Bax/Bcl-2 through the lectin-like Ox-LDL receptor–1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21:955–960
- Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther. 2002;302:601–605
- Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions. J Cardiovasc Pharmacol Ther. 2002;7:147–153
- Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia–reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol. 2003;41:1048–1055
- . Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ Res. 2004;94:892–901
- . Inflammation in atherosclerosis. Nature. 2002;420:868–874
- . Atherosclerosis. Nature. 2000;407:233–241
- In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res. 2005;97:152–158
- Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545–1556
- A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887–896
- Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovasc Res. 2004;64:243–249
- Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol. 1998;18:1541–1547
- Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor–1 in vascular endothelial cells. Circ Res. 1998;83:328–333
- Identification of soluble forms of lectin-like oxidized LDL receptor–1. Arterioscler Thromb Vasc Biol. 2000;20:715–720
- Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis. 2005;182:1–15
- LOX-1 mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells. Biochem J. 2006;393:107–115
- Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun. 1997;237:496–498
- Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci USA. 1998;95:9535–9540
- . Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature. 1988;331:168–170
- . Oxidized low-density lipoprotein, a two-faced Janus in coronary artery disease?. Biochem Pharmacol. 1998;56:279–284
- An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997;386:73–77
- Characterization of residues and sequences of the carbohydrate recognition domain required for cell surface localization and ligand binding of human lectin-like oxidized LDL receptor. J Cell Sci. 2001;114:1273–1282
- A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex. Eur J Immunol. 2001;31:3493–3503
- Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun. 2003;303:247–250
- Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages. J Atheroscler Thromb. 2002;9:57–64
- Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J. 1998;334(Pt 1):9–13
- . Scavenger receptor regulation and atherosclerosis. Biofactors. 2000;11:189–200
PII: S1050-1738(05)00223-9
doi: 10.1016/j.tcm.2005.12.001
© 2006 Elsevier Inc. All rights reserved.
« Previous
Trends in Cardiovascular Medicine
Volume 16, Issue 2
, Pages 60-64
, February 2006
